Ocular Findings after Allogeneic Hematopoietic Stem Cell Transplantation

Ophthalmology

Volumn 116, Issue 9, 2009, Pages 1624-1629

  Tabbara, Khalid F ^a,b,c   Al Ghamdi, Ahmad ^b   Al Mohareb, Fahad ^b   Ayas, Mouhab ^b   Chaudhri, Naeem ^b   Al Sharif, Fahad ^b   Al Zahrani, Hazzaa ^b   Mohammed, Said Y ^b   Nassar, Amr ^b   Aljurf, Mahmoud ^b  

^a The Eye Foundation for Research in Ophthalmology   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ALLERGIC CONJUNCTIVITIS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BIOMICROSCOPY; CATARACT; CHILD; CORNEA ULCER; DRY EYE; EYE DISEASE; EYE EXAMINATION; FEMALE; FUNGAL ENDOPHTHALMITIS; GLAUCOMA; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROPHYLAXIS; RETINITIS; SAUDI ARABIA; SCHIRMER TEST; SCHOOL CHILD; TONOMETRY; UVEITIS; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; CHILD; CYCLOSPORINE; EYE DISEASES; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; METHOTREXATE; MIDDLE AGED; OPHTHALMOSCOPY; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; VISUAL ACUITY;

EID: 69249180444     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.04.054     Document Type: Article

References (40)

1. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 11 (2005) 945-956
2. Cutler C., Giri S., Jeyapalan S., et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 19 (2001) 3685-3691
3. Martin P.J., Weisdorf D., Przepiorka D., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 12 (2006) 491-505
4. Chung H., Kim J.G., Choi S.H., et al. Bilateral toxoplasma retinochoroiditis simulating cytomegalovirus retinitis in an allogeneic bone marrow transplant patient. Korean J Ophthalmol 22 (2008) 197-200
5. Balaram M., Rashid S., and Dana R. Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf 3 (2005) 203-211
6. Karwacka E., Oldakowska-Jedynak U., Brydak-Godowska J., et al. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Transplant Proc 38 (2006) 292-294
7. Rojas B., Cuhna R., Zafirakis P., et al. Cell population and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res 81 (2005) 313-325
8. Kawase E., Azuma N., Shioda Y., and Kumagai M. Infantile case of occlusive microvascular retinopathy after bone marrow transplantation. Jpn J Ophthalmol 49 (2005) 318-320
9. Wang Y., Ogawa Y., Dogru M., et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 41 (2008) 293-302
10. Wertheim M., and Rosenbaum J.T. Bilateral uveitis manifesting as a complication of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Ocul Immunol Inflamm 13 (2005) 403-404
11. Balaram M., and Dana M.R. Phacoemulsification in patients after allogeneic bone marrow transplantation. Ophthalmology 108 (2001) 1682-1687
12. Suh D.W., Ruttum M.S., Stuckenschneider B.J., et al. Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 106 (1999) 1564-1570
13. Ng J.S., Lam D.S., Li C.K., et al. Ocular complications of pediatric bone marrow transplantation. Ophthalmology 106 (1999) 160-164
14. De Marco R., Dassio D.A., and Vittone P. A retrospective study of ocular side effects in children undergoing bone marrow transplantation. Eur J Ophthalmol 6 (1996) 436-439
15. Livesey S.J., Holmes J.A., and Whittaker J.A. Ocular complications of bone marrow transplantation. Eye 3 (1989) 271-276
16. Crippa F., Corey L., Chuang E.L., et al. Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation. Clin Infect Dis 32 (2001) 214-219
17. Kamoi M., Ogawa Y., Dogru M., et al. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res 32 (2007) 837-842
18. Song W.K., Min Y.H., Kim Y.R., and Lee S.C. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab. Ophthalmology 115 (2008) 1766-1770
19. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 12 (2006) 252-266
20. Arora M., Nagaraj S., Witte J., et al. New classification of chronic GVHD: added clarity from the consensus diagnoses. Bone Marrow Transplant 43 (2009) 149-153
21. Jagasia M., Giglia J., Chinratanalab W., et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant 13 (2007) 1207-1215
22. Tabbara K.F., Nassr A., Ahmed S.O., et al. Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation. Am J Ophthalmol 146 (2008) 462-465
23. Patriarca F., Skert C., Sperotto A., et al. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp Hematol 34 (2006) 389-396
24. Zhang C., Todorov I., Zhang Z., et al. Donor CD4+ T and B cells in transplant induce chronic graft-versus-host disease with autoimmune manifestations. Blood 107 (2006) 2993-3001
25. Pérez-Simón J.A., Encinas C., Silva F., et al. Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the National Institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy. Biol Blood Marrow Transplant 14 (2008) 1163-1171
26. Miyakoshi S., Kusumi E., Matsumura T., et al. Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. Biol Blood Marrow Transplant 13 (2007) 771-777
27. Pavletic S.Z., Lee S.J., Socie G., and Vogelsang G. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 38 (2006) 645-651
28. Mielke S., Solomon S.R., and Barrett A.J. Selective depletion strategies in allogeneic stem cell transplantation. Cytotherapy 7 (2005) 109-115
29. Solomon S.R., Mielke S., Savani B.N., et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 106 (2005) 1123-1129
30. Lee S.J., Klein J.P., Barrett A.J., et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100 (2002) 406-414
31. Adrean S.D., and Puklin J.E. Perforated corneal ulcer with subsequent endophthalmitis in a patient with graft-versus-host disease. Cornea 26 (2007) 107-108
32. Couriel D.R., Saliba R., Escalon M.P., et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 130 (2005) 409-417
33. Busca A., Locatelli F., Marmont F., et al. Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease. [letter]. Haematologica 88 (2003) 837-839
34. Lopez F., Parker P., Nademanee A., et al. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 11 (2005) 307-313
35. Akpek G., Lee S.M., Anders V., and Vogelsang G.B. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biol Blood Marrow Transplant 7 (2001) 495-502
36. Arora M., Wagner J.E., Davies S.M., et al. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 7 (2001) 265-273
37. Lee S.J., Kim H.T., Ho V.T., et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 38 (2006) 305-310
38. Fraser C.J., Bhatia S., Ness K., et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 108 (2006) 2867-2873
39. Strauss L., Whiteside T.L., Knights A., et al. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 178 (2007) 320-329
40. Sall K., Stevenson O.D., Mundorf T.K., Reis B.L., and CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 107 (2000) 631-639